Always have the latest information at your fingertips.
MedForecast® brings the power of real-time data collection, integrative analytics and Bayesian inference modeling to yield exceptionally accurate drug approval and launch predictions, saving you time and ensuring that you always have the latest information at your fingertips.
Precision / Accuracy
MedForecast® brings the power of real-time data collection, integrative analytics and Bayesian inference modeling to yield exceptionally accurate drug approval and launch predictions, saving you time and ensuring that your enterprise always has the latest information at your fingertips. Medforecast® is virtually the only predictive analytics tool that can provide the tracking and forecasting modules to accurately determine a drug treatment’s milestone dates, from initial product development to clinical trials on up to approval and market launch. dates from vast stores of available pharma research and development data in the R&D, testing, and government approval pipeline.
MedForecast® is arguably the most proactive intelligence tool available today serving the highly competitive Pharma industry. Managed through a highly nimble search engine and GUI optimized for speed as well as accuracy. MedForecast® gives your business the power to quickly anticipate market disruptors, predict drug approvals in advance, and protect its own financial well-being in the process. It has the capability to help your organization make strategic investment decisions.
MedForecast® is specifically designed and built to run on automation—using advanced RPA protocols—to continuously update important, time-sensitive data assets that can potentially impact your business decisions. This under-the- hood technology layer minimizes human error and saves your organization valuable time and resources, delivering real-time results that stakeholders can rely on to make intelligent choices. MedForecast® is also meant to be flexible, running on most operating platforms, including iOS, Android, and Microsoft as a cloud-based service to keep your business connected to the latest information, no matter, where you are or what device you use.
Robust in Oncology and Cardiology
Oncology and Cardiology are among the most researched specialties in healthcare today. For those pharma enterprises and investment firms that have a financial stake in R&D and testing for new drug therapies in these discplines, MedForcast® offers outstanding opportunities to stay ahead of the competitive curve to bring life-saving treatments and improve quality of life for multitudes of patient groups.
A key benefit for users of MedForecast® is its comprehensive functionality. Subscribers can create hierarchical sort and reporting functions, and can also employ filter options, such as treatments in specific medical specialties, or drug categories, for example.